Altimmune, Inc. (ALT)

CIK 1326190 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Altimmune, Inc..

Recent SEC filings

FiledFormAccession number
Aug 13, 202640001698665-26-000007
Aug 12, 202610-Q0001326190-26-000052
Aug 12, 20268-K0001326190-26-000049
Aug 3, 202640001251779-26-000009
Aug 3, 202640001705905-26-000010
Jul 28, 20268-K0001326190-26-000044
Jun 16, 20268-K0001104659-26-074575
May 15, 2026SCHEDULE 13G/A0001214659-26-006495
May 13, 2026S-80001326190-26-000041
May 13, 202610-Q0001326190-26-000040
May 13, 20268-K0001326190-26-000037
May 12, 2026SCHEDULE 13G0000093751-26-000201
May 1, 2026SCHEDULE 13G0000905148-26-002008
May 1, 202640001527204-26-000002
May 1, 202640001409939-26-000004
May 1, 202640001960596-26-000002
May 1, 202640001705562-26-000002
May 1, 2026SCHEDULE 13G0001346824-26-000125
May 1, 2026SCHEDULE 13G0001193125-26-201587
May 1, 202640001743611-26-000004
May 1, 202640001705904-26-000002
May 1, 202640001555132-26-000008
May 1, 202640001201196-26-000002
Apr 30, 2026SCHEDULE 13G0001172661-26-001579
Apr 24, 20268-K0001104659-26-048552